208 POSTER A phase II study of sunitinib, an oral multi-targeted tyrosine kinase inhibitor, in patients with unresectable, locally advanced or metastatic cervical carcinoma: IND184

✍ Scribed by H. Mackay; A. Tinker; E. Winquist; G. Thomas; J. Sederias; P. Ivy; E.A. Eisenhauer

• Book ID: 119599363
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 79 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)72140-2